iRhythm Holdings — Third Quarter 2026 Earnings Summary

iRhythm Holdings reported third-quarter 2026 revenue of $221.6 million, representing a 14.9% increase from the prior year period, driven by strong volume demand for its Zio Monitor. The company achieved a gross margin of 74.2% and reported an adjusted EBITDA of $51.2 million, reflecting significant margin expansion and operational efficiencies. On October 5, 2026, iRhythm completed its acquisition of VitalConnect to expand its cardiac monitoring portfolio with an FDA-cleared mobile cardiac telemetry offering. Consequently, the company raised its full-year 2026 revenue guidance to a range of $890 million to $895 million and adjusted EBITDA margin guidance to 15.5% to 16.0%.